IP GROUP
MedaPhor Group plc (AIM: MED) ('MedaPhor'), the global provider of advanced ultrasound education and training for medical professionals, is to present at the Innovators & Investors Forum, a Shares Magazine event sponsored by Cenkos Securities, at the Business Design Centre, 52 Upper Street, London N1 0QH on Tuesday 3 February 2015.
Stuart Gall, CEO of MedaPhor, will deliver the presentation in the Babbage Room at 10.10am. He will also be available at stand 3 to meet current and prospective investors and others to show the Company's products, provide information and answer any questions. No new material information will be disclosed.
The one-day forum starts at 9am and will showcase up to 40 pioneering and imaginative technology-led firms, bringing them together with the investment community. Aimed primarily at private investors, with some professional investors also likely to attend, the event combines a company expo and an educational conference where delegates learn about investment opportunities.
The event has an extensive conference program, including keynote speakers and company presentations. Details are available at: http://www.sharesmagazine.co.uk/events/event/iif2015/
For further information please contact:
Medaphor plc
Stuart Gall
stuart.gall@medaphor.com
+44 (0) 2920 756534
Nominated Adviser and Broker
Cenkos Securities
Bobbie Hilliam / Harry Pardoe, Nominated Adviser
Julian Morse, Corporate Broking
+44 (0) 20 7397 8900
Media enquiries
Allerton Communications
Peter Curtain
peter.curtain@allertoncomms.co.uk
+44 (0) 20 3137 2500
Notes to editors
MedaPhor (www.medaphor.com), based in Cardiff in the UK and San Diego in the USA, is a global provider of advanced ultrasound education and training for medical professionals. Our aim is simple - to build a world class ultrasound training company with educational excellence as its core guiding principle. MedaPhor's revolutionary ScanTrainer simulator teaches doctors and sonographers the complex, hard-to-learn ultrasound scanning skills, without the need for patients and with minimal expert supervision.
|
distributed by
|
